A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis

A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis

Abstract Background PARP inhibitors (PARPis) have shown promising effectiveness for ovarian cancer. This network meta-analysis (PROSPERO registration number CRD42024503390) comprehensively evaluated the effectiveness and safety of PARPis in platinum-sensitive recurrent ovarian cancer (PSROC). Method...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shiya Ji, Lu Chen, Yebo Yu, Xupeng Chen, Liwen Wei, Lili Gou, Cheng Shi, Susu Zhuang
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Journal of Ovarian Research
Subjects:	Network meta-analysis Ovarian cancer Poly (ADP-ribose) polymerase inhibitor Platinum-sensitive recurrent ovarian cancer Overall survival Progression-free survival
Online Access:	https://doi.org/10.1186/s13048-025-01599-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Blast‐Overpressure Induced Modulation of PARP‐SIRT‐NRF2 Axis in Stress Signaling of Astrocytes and Microglia
by: Vijaya Prakash Krishnan Muthaiah, et al.
Published: (2025-01-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Comparative analysis of the primary structure and production of recombinant poly(ADP-ribose)polymerase 1 of long-lived Heterocephalus glaber
by: K. N. Naumenko, et al.
Published: (2024-11-01)

PARP Inhibitors in the Treatment of Ovarian Cancer
by: Andrzej Paweł Zuzak, et al.
Published: (2025-02-01)

Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01)

Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial
by: Su H, et al.
Published: (2025-02-01)

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
by: Michela Roberto, et al.
Published: (2025-01-01)

The effect of waiting time on ovarian cancer survival in oncology centres, Addis Ababa, Ethiopia: a retrospective cohort study
by: Abrham Tesfaye Habteyes, et al.
Published: (2025-01-01)

Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
by: Yuan-Ting C. Lo, et al.
Published: (2023-04-01)

Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy
by: Yiwen Qiu, et al.
Published: (2025-02-01)

Association between plasma perfluoroalkyl substances and high-grade serous ovarian cancer overall survival: A nested case-control study
by: Wei-Yi Xing, et al.
Published: (2025-02-01)

Determining the effect of frailty on survival in advanced ovarian cancer: study protocol for a prospective multicentre national cohort study (FOLERO)
by: Daniel Hunde, et al.
Published: (2025-02-01)

Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
by: Meng Yan, et al.
Published: (2025-01-01)

Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer
by: Yilong Huang, et al.
Published: (2025-02-01)

Patients with colorectal cancer combined with HIV had a worse overall survival after surgery: a meta-analysis
by: Wen-Wen Yang, et al.
Published: (2025-01-01)

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
by: Yinan Xiao, et al.
Published: (2025-01-01)

Assessment of Ki-67 expression in cases of prostatic carcinoma and its correlation with clinical outcomes
by: Sumaira Siddiqui
Published: (2024-04-01)

Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study
by: Seyed Mohamad Sadegh Mousavi-kiasary, et al.
Published: (2025-02-01)

ConvXGB: A novel deep learning model to predict recurrence risk of early-stage cervical cancer following surgery using multiparametric MRI images
by: Ji Wu, et al.
Published: (2025-02-01)

Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
by: Youzhao Ma, et al.
Published: (2024-12-01)

Association of pre- and post-diagnosis dietary total antioxidant capacity (TAC) and composite dietary antioxidant index (CDAI) with overall survival in patients with ovarian cancer: a prospective cohort study
by: Dong-Dong Wang, et al.
Published: (2025-01-01)

A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights
by: Ridwan S, et al.
Published: (2025-01-01)

Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
by: Linna Gao, et al.
Published: (2025-02-01)

Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancer
by: Sangsang Tang, et al.
Published: (2025-02-01)

Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer
by: Baoli Li, et al.
Published: (2025-01-01)

Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis
by: Jing Sun, et al.
Published: (2025-01-01)

Nomogram prediction of overall survival in breast cancer patients post-surgery: integrating SEER database and multi-center evidence from China
by: Yufen Zheng, et al.
Published: (2025-01-01)

Jejunal Fistula Complicating Ovarian Serous Carcinoma: Case Report of a Rare Phenomenon and Review of the Literature
by: Isin Ureyen, et al.
Published: (2021-08-01)

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
by: Wen‐Qi Liu, et al.
Published: (2024-12-01)

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
by: Yaqin Dong, et al.
Published: (2025-02-01)

Development and validation of a prognostic prediction model for elderly gastric cancer patients based on oxidative stress biochemical markers
by: Xing-Qi Zhang, et al.
Published: (2025-02-01)

Poly-ADP ribose polymerase (PARP) inhibitor regimens for platinum-sensitive ovarian cancer in randomized, double-blind, phase III controlled trials: protocol for a systematic review and network meta-analysis
by: Xiaolian Peng, et al.
Published: (2025-01-01)

CURRENT POSSIBILITIES OF MAGNETIC – RESONANCE IMAGING IN DETECTION OF OVARIAN CANCER
by: N. A. Rubtsova, et al.
Published: (2017-03-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01)

7,12-Dimethylbenz(a)anthracene as a Model for Ovarian Cancer Induction in Rats
by: Ana Carolina Ciseski Gonçalves, et al.
Published: (2025-01-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells
by: Xuanhe Fu, et al.
Published: (2025-02-01)

Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study
by: Lin Cheng Han, et al.
Published: (2024-12-01)

Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01)